TENGJUN BIOTECHNOLOGY CORP. : Other Events (form 8-K)

Item 8.01 Other Events.

On March 30, 2022, the board of directors (the "Board") of Tengjun Biotechnology Corp. (the "Company") adopted a resolution, subject to the Company's shareholder approval, to increase its authorized capital from 70,000,000 to 200,000,000 shares of its common stock (the "Increase in Authorized Capital") by amending and restating the Company's articles of incorporation.

                                       1

© Edgar Online, source Glimpses